B7-H3 (B7 homolog 3 protein) (CD 276), an immune checkpoint molecule that is widely expressed on activated T cells, monocytes, and dendritic cells, is overexpressed in multiple cancer types, thus making it a promising immunotherapy target [34,36,37]. The gene discussed is CD276; the disease is cancer.